Company

Splice Bio

Biotechnology - Therapeutics and Diagnostics

 

Splice Bio is a gene therapy company based on technology developed at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations of adeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.

+34 934 020 456

info@splice.bio

splice.bio


Contact person: Silvia Frutos Domínguez

Location: Ed. Clúster - 03C71